Gold expected to reach $4,600–$4,800 an ounce in 2026, says Ventura

Ventura forecasts gold prices to reach $4,600–$4,800 an ounce in 2026, driven by central bank buying, inflation, US deficits, and Federal Reserve rate cuts.

Ventura forecasts gold prices to reach $4,600–$4,800 an ounce in 2026, driven by central bank buying, inflation, US deficits, and Federal Reserve rate cuts.

Monday’s sell-off was across sectors, with the sharpest pain in the broader markets. The Midcap index logged its biggest fall in four months.

Moody’s downgraded IndiGo’s human capital issuer score to 4 from 3 due to the adverse impact of slower hiring. The rating agency said IndiGo’s disruptions exposed gaps, which could result in revenue loss from cancellations, refunds and potential penalties. Shares…

At its height, IndiGo was valued at $27.3 billion, placing it at the top of the global airline market-cap table. But a seven-session losing streak has wiped out nearly $4.5 billion in value — a decline almost equal to the…

SEBI will ban live market data in investor-education content and launched PaRRVA to verify past returns, aiming to curb misleading finfluencer claims and improve investor protection.

The Reserve Bank of India, through its letter dated September 12, 2025, accorded approval for the bank to purchase up to 2% additional shareholding, subject to compliance with applicable regulations. Shares of ICICI Bank Ltd ended at ₹1,389.40, down by…

The product is a generic therapeutic equivalent version of the Reference Listed Drug (RLD) from Mallinckrodt Pharmaceuticals Ireland Ltd. Shares of Caplin Point Laboratories Ltd ended at ₹1,961.00, down by ₹2.05, or 0.10%, on the BSE.

The total contract value exceeds 485 million SAR, approximately ₹1,165 crore, including value-added tax. The contract tenure is six months.Shares of Welspun Corp Ltd ended at ₹797.70, down by ₹29.70, or 3.59%, on the BSE.

India saw strong gold demand and record price highs throughout 2025. Financial investment in gold is rising with younger buyers increasingly choosing ETFs and digital channels. Jewellery purchases are supported by higher incomes and more transparency, while value growth continues…

Chola Securities expects Biocon to see further correction over the next year as its merger leads to earnings dilution and higher debt costs. Profit growth and returns have stayed weak, and recovery to double-digit growth may take time. In the…